Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Board changes

22 Dec 2010 07:00

RNS Number : 4068Y
Arden Partners plc
22 December 2010
 

Arden Partners plc

Board changes

 

Arden Partners plc ("Arden" or the "Company") is pleased to announce the appointment of Mark Ansell and Peter Moon as Independent Non-Executive Directors with effect from 31st December 2010 and subject to FSA Regulatory approval.

 

Mark Ansell is a Chartered Accountant and has significant experience as a business consultant and director involved in strategic and corporate finance advice and in management and leadership roles. Mark has held previously senior roles in many organisations including being the Deputy Chief Executive and Finance Director of Aston Villa plc, Interim Chief Executive of Marketing Birmingham and a Senior Partner and Partner in charge of Corporate Finance of Deloitte in Birmingham and the Midlands. Mark will assume the role as Chairman of the Audit Committee. Further disclosures relating to Mark are set out below.

 

Peter Moon has been involved in the institutional investment business for many years. In 2009 Peter retired from the Universities Superannuation Scheme Limited where he was Chief Investment Officer running a fund of some £27.5 billion. The previous institutions where Peter has worked include British Airways Pensions, National Provident and Slater Walker Investment Management. Peter has also acted as adviser to a number of Councils including Lincolnshire and Middlesbrough. He has served as Chairman of the NAPF Stock Exchange Sub-Committee and as a member of the NAPF Investment Committee.

 

The Board of Arden is also pleased to announce, with immediate effect, the appointment of Steve Wassell, the Company's Chief Operating Officer as an Executive Director.

 

The Company also announces the retirement of Tony Bartlett with effect from 31st December 2010. Tony has been involved with Arden since the early days of its inception in 2002 and has played an important role in its development and has carried out many roles for the Company including Chief Executive Officer, Chairman of Corporate Finance and since 2008 as a non-executive director. The Board wishes to thank Tony for his significant contribution to Arden and wishes him well in his retirement.

 

Enquiries:

 

Arden Partners plc

020 7614 5900

Jonathan Keeling - Chief Executive Officer

Trevor Norris - Group Finance Director

 

 

 

Altium 

020 7484 4040

Phil Adams

 

Sam Fuller

 

 

 

Buchanan Communications

020 7466 5000

Mark Edwards

 

Further information

Mark Ansell

Save as set out below, Mark John Ansell (58) has confirmed that there is nothing further to disclose in relation to his appointment to the Board of Arden under Schedule 2, paragraph (g) of the AIM rules for Companies.

 

Details of all companies and partnerships of which Mark Ansell is or has been a director or partner at any time during the past five years:

Current

Past

Amorartis Limited

Chase Midland plc (administration April 2008)

De Montfort Fine Art Limited

 

Mark Ansell Consulting Limited

 

Player Data Analysis Limited

 

RG Parkside Limited

 

Scout7 EBT Limited

 

Scout7 Holdings Limited

 

Scout7 Limited

 

Team Academy Pro Limited

 

Venture 7 Limited

 

Whitewall Galleries Limited

 

 

Peter Moon

Save as set out below, Peter Geoffrey Moon (61) has confirmed that there is nothing further to disclose in relation to his appointment to the Board of Arden under Schedule 2, paragraph (g) of the AIM rules for Companies.

 

Details of all companies and partnerships of which Peter Moon is or has been a director or partner at any time during the past five years:

Current

Past

First Property Group PLC

First Property General Partner Limited

The Scottish American Investment Company PLC

MBNA Europe Bank Limited

 

Universities Investment Management Limited

 

USS Asset Management Limited

 

USS Investment Management Limited

 

 

 

Steve Wassell

Save as set out below, Stephen Michael Wassell (51) has confirmed that there is nothing further to disclose in relation to his appointment to the Board of Arden under Schedule 2, paragraph (g) of the AIM rules for Companies.

 

Details of all companies and partnerships of which Stephen Wassell is or has been a director or partner at any time during the past five years:

Current

Past

None

None

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUARKRRKAUUAA
Date   Source Headline
3rd Jul 201712:45 pmRNSHolding(s) in Company
3rd Jul 201712:44 pmRNSHolding(s) in Company
30th Jun 20178:56 amRNSDirector/PDMR Shareholding
29th Jun 201711:07 amRNSResult of Meeting and Total Voting Rights
12th Jun 20178:21 amRNSResult of Placing
12th Jun 20177:01 amRNSProposed Placing
12th Jun 20177:00 amRNSInterim Results - Six Months Ended 30 April 2017
25th May 20177:00 amRNSDirectorate Changes and Possible Fundraising
13th Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 201711:50 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 20178:21 amRNSPossible offer by Dolphin for FIH Group
9th Mar 201712:17 pmRNSResult of AGM
9th Mar 201710:57 amRNSAGM Statement
13th Feb 201711:31 amRNSBlock Listing Six Monthly Return
7th Feb 20172:40 pmRNSPublication of Annual Report and Notice of AGM
3rd Feb 201711:28 amRNSTransaction in Own Shares and Total Voting Rights
1st Feb 20172:09 pmRNSProposed Award of Share Options
26th Jan 20177:00 amRNSPreliminary Results - Year Ended 31 October 2016
6th Jan 201711:50 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201612:30 pmRNSForm 8.5 (EPT/NON-RI) AMENDMENT
1st Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
30th Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 201612:17 pmRNSForm 8.5 (EPT/NON-RI)
2nd Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
28th Oct 201612:27 pmRNSHolding(s) in Company
28th Oct 201612:12 pmRNSHolding(s) in Company
28th Oct 201611:03 amRNSHolding(s) in Company
28th Oct 201610:44 amRNSHolding(s) in Company
28th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20167:00 amRNSPersonnel Change
6th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
4th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
26th Sep 201611:49 amRNSForm 8.5 (EPT/NON-RI)
20th Sep 201611:50 amRNSForm 8.5 (EPT/NON-RI)
16th Sep 20162:19 pmRNSForm 8.5 (EPT/NON-RI)
19th Aug 201612:08 pmRNSHolding(s) in Company
12th Aug 201611:25 amRNSBlocklisting Six Monthly Return
11th Aug 201610:10 amRNSForm 8.5 (EPT/NON-RI)
2nd Aug 20167:00 amRNSDirector/PDMR Shareholding
1st Aug 20167:30 amRNSChange of Name of Nominated Adviser
28th Jul 20167:00 amRNSInterim Results - Six Months Ended 30 April 2016
21st Jul 201611:50 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 201611:23 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
9th Jun 20169:44 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.